Viewing Study NCT03636906


Ignite Creation Date: 2025-12-26 @ 2:43 PM
Ignite Modification Date: 2026-03-01 @ 11:15 PM
Study NCT ID: NCT03636906
Status: COMPLETED
Last Update Posted: 2022-07-27
First Post: 2018-08-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 204894
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators